A dual antiplatelet therapy regimen of up to 24 months was associated with a significantly lower risk of death, MI or cerebrovascular accidents in patients with peripheral artery disease (PAD) who underwent PCI.

The use of beta-blockers in older adults with stable angina who underwent PCI did not reduce the adjusted mortality rate, MI, stroke or revascularization, according to retrospective, observational registry analysis.

While blood pressure drugs have been successful at pushing patient’s systolic blood pressure down to 120—the recognized benchmark for a healthy blood pressure—they have also dropped diastolic blood pressure to potentially dangerous levels.

The FDA approved a bolus vial form of tirofiban hydrochloride (Aggrastat) on Sept. 1.

Advanced imaging technologies and techniques were used this summer to successfully separate two conjoined twin girls.

Googling symptoms to make a diagnosis is not medical best practice. But now, thanks to a collaborative effort between the American College of Cardiology and the world’s most popular search engine, Google searches for heart conditions will produce important questions patients should ask their doctors based on ACC clinical guidelines.

Millions of patients each year undergoing PCI are implanted with drug-eluting or bare-metal stents. Comparisons between the types of stents have been limited, although a recent randomized study in Norway showed similar outcomes between the two categories.

The American College of Cardiology recently published findings in JACC: Basic to Translational Science that show the pace of innovation and investment in developing new cardiovascular therapeutics has decreased over the past 22 years.